In this study, we provide evidence of a compartmentalized reduction of CaM levels at the plasma membrane of CD8+ T cells of HNSCC patients that selectively impacts KCa3.1 activity and chemotaxis. This evidence concerns the gene CALM2 and head and neck squamous cell carcinoma.